Cargando…

Coexistence of cystic fibrosis and phenylketonuria.

Detalles Bibliográficos
Autores principales:	Greeves, L. G., McCarthy, H. L., Redmond, A., Carson, D. J.
Formato:	Texto
Lenguaje:	English
Publicado:	Ulster Medical Society 1997
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2448703/ https://www.ncbi.nlm.nih.gov/pubmed/9185493

Ejemplares similares

Coexistence of Candida species and bacteria in patients with cystic fibrosis
por: Haiko, Johanna, et al.
Publicado: (2019)

Showing Value in Newborn Screening: Challenges in Quantifying the Effectiveness and Cost-Effectiveness of Early Detection of Phenylketonuria and Cystic Fibrosis
por: Grosse, Scott D.
Publicado: (2015)

Severe mental retardation due to maternal phenylketonuria.
por: Nevin, N. C., et al.
Publicado: (1982)

Pseudomonas aeruginosa Alginate Overproduction Promotes Coexistence with Staphylococcus aureus in a Model of Cystic Fibrosis Respiratory Infection
por: Limoli, Dominique H., et al.
Publicado: (2017)

Phenylketonuria
por: Hudson, Frederick
Publicado: (1969)

Coexistence and Within-Host Evolution of Diversified Lineages of Hypermutable Pseudomonas aeruginosa in Long-term Cystic Fibrosis Infections
por: Feliziani, Sofía, et al.
Publicado: (2014)

Ivacaftor for the Treatment of Cystic Fibrosis Coexisting with Trisomy 21: A Case Report
por: Charbek, Edward, et al.
Publicado: (2019)

Prevalence and survival of patients with cystic fibrosis in Northern Ireland, 1961-1971.
por: Nevin, G. B., et al.
Publicado: (1983)

Food insecurity in females with phenylketonuria
por: Coakley, Kathryn E., et al.
Publicado: (2020)

Factors influencing physical activity in adults with cystic fibrosis
por: Hurley, Nicola, et al.
Publicado: (2021)

Staphylococcus aureus and Pseudomonas aeruginosa Isolates from the Same Cystic Fibrosis Respiratory Sample Coexist in Coculture
por: Bernardy, Eryn E., et al.
Publicado: (2022)

Carbohydrate status in patients with phenylketonuria
por: Couce, María L., et al.
Publicado: (2018)

Antibiotic potentiation and inhibition of cross-resistance in pathogens associated with cystic fibrosis
por: Kadeřábková, Nikol, et al.
Publicado: (2023)

A pilot study demonstrating the altered gut microbiota functionality in stable adults with Cystic Fibrosis
por: Fouhy, F., et al.
Publicado: (2017)

Cystic fibrosis disease severity correlates with plasma levels of desmosine and isodesmosine, biomarkers of elastin degradation
por: Ma, Shuren, et al.
Publicado: (2019)

TMEM16A Potentiation: A Novel Therapeutic Approach for the Treatment of Cystic Fibrosis
por: Danahay, Henry L., et al.
Publicado: (2020)

Not Quite the Bully in the Schoolyard: Staphylococcus aureus Can Survive and Coexist with Pseudomonas aeruginosa in the Cystic Fibrosis Lung
por: Wolter, Daniel J., et al.
Publicado: (2021)

Recommendations to improve physical activity prescription for the cystic fibrosis population: an Irish perspective
por: Hurley, Nicola, et al.
Publicado: (2020)

Airway inflammatory markers in individuals with cystic fibrosis and non-cystic fibrosis bronchiectasis
por: Bergin, David A, et al.
Publicado: (2013)

Characterizing Mucociliary Clearance in Young Children with Cystic Fibrosis
por: Laube, Beth L., et al.
Publicado: (2022)

The microbiology associated with cystic fibrosis
por: McGowan, Karin L.
Publicado: (1988)

SCREENING FOR PHENYLKETONURIA IN CHRONIC PSYCHIATRIC INPATIENTS
por: Tadas, A.K., et al.
Publicado: (1999)

Carcinogenic Effects in a Phenylketonuria Mouse Model
por: Sidell, Neil, et al.
Publicado: (2009)

Patient with Phenylketonuria and Intellectual Disability—Problem Not Always Caused Exclusively by Insufficient Metabolic Control (Coexistence of PKU and Alazami Syndrome)
por: Patalan, Michał, et al.
Publicado: (2022)

Infections in cystic fibrosis
por: Marks-Austin, Kathy A., et al.
Publicado: (1995)

Acute inhalation of hypertonic saline does not improve mucociliary clearance in all children with cystic fibrosis
por: Laube, Beth L, et al.
Publicado: (2011)

Cystic Fibrosis
por: Dodge, J A
Publicado: (1997)

The readability of online health resources for phenylketonuria
por: Marsh, Jessie M., et al.
Publicado: (2020)

US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis
por: Floto, R Andres, et al.
Publicado: (2016)

Early feeding practices in infants with phenylketonuria across Europe
por: Pinto, A., et al.
Publicado: (2018)

A cohort study of cystic fibrosis and malignancy.
por: Sheldon, C. D., et al.
Publicado: (1993)

The Use of Glycomacropeptide in Dietary Management of Phenylketonuria
por: Zaki, Osama K., et al.
Publicado: (2016)

ROCK STUDY in CF: sustained anti-inflammatory effects of lumacaftor–ivacaftor in sputum and peripheral blood samples of adult patients with cystic fibrosis—an observational study
por: Arooj, Parniya, et al.
Publicado: (2023)

Improving performance in the detection and management of cystic fibrosis-related diabetes in the Mountain West Cystic Fibrosis Consortium
por: Liou, Theodore G, et al.
Publicado: (2016)

Quality of life and adherence to treatment in early-treated Brazilian phenylketonuria pediatric patients
por: Vieira, E., et al.
Publicado: (2017)

The cardiovascular phenotype of adult patients with phenylketonuria
por: Azabdaftari, Aline, et al.
Publicado: (2019)

US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summary
por: Floto, R Andres, et al.
Publicado: (2016)

The Adult Phenylketonuria (PKU) Gut Microbiome
por: Mancilla, Viviana J., et al.
Publicado: (2021)

Molecular genetics of phenylketonuria and tetrahydrobiopterin deficiency in Jordan
por: Carducci, Carla, et al.
Publicado: (2020)

Nebuliser hygiene in cystic fibrosis: evidence-based recommendations
por: Bell, Jane, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_g0q9j935g6b1pd1l1mhk106eeh